Vivex Biologics, Inc.

A conditional approval pathway for cell therapies is likely to receive legislative attention in the next round of user fee reauthorization in 2017. The proposal has been introduced in the form of the

Financings Life science start-up companies raised a total of $1.8 billion in the first quarter of 2016, $579 million less than the previous quarter. Thirty-seven biopharma companies combined for $1.3

It’s awards season, as they say in Hollywood, and a bit later, this column has a red-carpet treat for its readers: The 2013 A-List winners. But first, fresh 2013 U.S. venture data fresh has arrived. F